Basic research in substantia nigra and ventral tegmental area: clinical implications

F Stratta; A Bonci; P Calabresi; A Stefani; A Pisani; G Bernardi; N B Mercuri

Basic research in substantia nigra and ventral tegmental area: clinical implications

J Neural Transm Suppl. 1995:45:47-55.

Authors

F Stratta¹, A Bonci, P Calabresi, A Stefani, A Pisani, G Bernardi, N B Mercuri

Affiliation

¹ Università di Tor Vergata, Roma, Italy.

PMID: 8748608

Abstract

In this review we will briefly examine some physiological and pharmacological aspects of the dopaminergic and non-dopaminergic cells of the midbrain in relationship to pathological conditions such as extrapyramidal disorders, mental illness, drug seeking behaviour and epilepsy.

Publication types

Review

MeSH terms

Animals
Basal Ganglia Diseases / drug therapy
Basal Ganglia Diseases / pathology
Basal Ganglia Diseases / physiopathology
Dopamine / physiology*
Epilepsy / drug therapy
Epilepsy / pathology
Epilepsy / physiopathology
Humans
Mental Disorders / drug therapy
Mental Disorders / pathology
Mental Disorders / physiopathology
Parkinson Disease / drug therapy
Parkinson Disease / pathology
Parkinson Disease / physiopathology
Substance-Related Disorders / drug therapy
Substance-Related Disorders / pathology
Substance-Related Disorders / physiopathology
Substantia Nigra / drug effects
Substantia Nigra / pathology
Substantia Nigra / physiopathology*
Ventral Tegmental Area / drug effects
Ventral Tegmental Area / pathology
Ventral Tegmental Area / physiopathology*

Substances

Dopamine